Canada markets close in 3 hours 42 minutes

ProQR Therapeutics N.V. (PRQR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
7.14-0.05 (-0.70%)
As of 12:14PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close7.19
Open7.25
Bid7.13 x 1000
Ask7.15 x 800
Day's Range7.05 - 7.25
52 Week Range3.40 - 9.46
Volume76,626
Avg. Volume686,612
Market Cap526.297M
Beta (5Y Monthly)0.30
PE Ratio (TTM)N/A
EPS (TTM)-1.09
Earnings DateFeb. 23, 2022 - Feb. 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.72
  • GlobeNewswire

    ProQR Announces Highlights from Analyst Event

    LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today hosted a virtual Analyst Event. Management provided an in-depth review of the Company’s clinical-stage programs and RNA editing technology platforms. A webcast replay of the event including slides is available from the “Investors & Media” section

  • GlobeNewswire

    ProQR to Webcast Virtual Analyst Event on November 18

    LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, will webcast a virtual Analyst Event on November 18, 2021, from 12-2pm ET to highlight its clinical stage pipeline programs and the Axiomer® RNA editing platform. ProQR leadership will highlight key advancements from its clinical-stage pipeline, includi

  • GlobeNewswire

    ProQR Announces Upcoming Investor Conferences in November and December

    LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that Company management will participate in the following upcoming investor conferences: Stifel 2021 Virtual Healthcare Conference Monday, November 15, 11:20-11:50am EST – Fireside chatEvercore ISI 4th Annual HealthCONx ConferenceThursda